Tom Cohen

A New Cancer-Killing Bispecific Antibody Working Toward the Clinic in 2022

—

by

Tom Cohen
in

The joint development project by Alligator Bioscience and Aptevo Therapeutics, ALG.APV-527, shows potential in targeting solid tumours

Read More

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *